Kanagawa, Japan

Syuichiro Kadowaki

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Kasei Corporation. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Syuichiro Kadowaki. Retrieved from https://idiyas.com/inventor/syuichiro-kadowaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Syuichiro Kadowaki: Innovator in Steroid Derivatives

Introduction

Syuichiro Kadowaki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid derivatives. His innovative work has led to advancements in therapeutic agents for osteopathy.

Latest Patents

Kadowaki holds a patent for steroid derivatives, specifically a therapeutic agent for osteopathy. The patent describes an asteroid derivative of the general formula, wherein X--O-- represents a residue of a steroid compound. The formula also includes various components that enhance the therapeutic efficacy of the steroid derivative.

Career Highlights

Kadowaki is associated with Mitsubishi Kasei Corporation, where he has been instrumental in research and development. His work focuses on creating effective therapeutic solutions that address various medical conditions. His dedication to innovation has positioned him as a key figure in his field.

Collaborations

Throughout his career, Kadowaki has collaborated with esteemed colleagues such as Hiroaki Ueno and Akihito Kamizono. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Syuichiro Kadowaki's contributions to the field of steroid derivatives exemplify his commitment to innovation in pharmaceuticals. His work continues to impact the development of therapeutic agents, showcasing the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…